Security Snapshot

NATIONAL HEALTHCARE CORP - Common Stock (NHC) Institutional Ownership

CUSIP: 635906100

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

233

Shares (Excl. Options)

10,237,611

Price

$159.70

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Type / Class
Equity / Common Stock
Symbol
NHC on NYSE
Shares outstanding
15,544,129
Price per share
$157.97
All holders as of 31 Mar 2026
Q1 2026
Total 13F shares
10,237,611
Total reported value
$1,635,148,783
% of total 13F portfolios
0%
Share change
+285,193
Value change
+$51,064,373
Number of holders
233
Price from insider filings
$157.97
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • NHC - NATIONAL HEALTHCARE CORP - Common Stock is tracked under CUSIP 635906100.
  • 233 institutions reported positions in Q1 2026.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 222 to 233 between Q4 2025 and Q1 2026.
  • Reported value moved from $1,364,489,531 to $1,635,148,783.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 233 institutions filings for Q1 2026.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 635906100?
CUSIP 635906100 identifies NHC - NATIONAL HEALTHCARE CORP - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q1 2026 holders report and the ownership history table below.

Significant Owners of NATIONAL HEALTHCARE CORP - Common Stock (NHC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 12% $218,759,921 1,800,345 BlackRock, Inc. 30 Sep 2025
MORGAN STANLEY 7.1% $185,590,053 1,102,537 Morgan Stanley 31 Dec 2025
VANGUARD PORTFOLIO MANAGEMENT LLC 5.1% $126,850,508 794,305 Vanguard Portfolio Management 31 Mar 2026

As of 31 Mar 2026, 233 institutional investors reported holding 10,237,611 shares of NATIONAL HEALTHCARE CORP - Common Stock (NHC). This represents 66% of the company’s total 15,544,129 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of NATIONAL HEALTHCARE CORP - Common Stock (NHC) together control 58% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 12% 1,895,250 -0.36% 0.01% $302,671,444
Morgan Stanley Institutional Investment Advisors LLC 6.7% 1,038,804 +0% 16% $165,896,999
DIMENSIONAL FUND ADVISORS LP 6.1% 946,977 -1.2% 0.03% $151,237,141
VANGUARD PORTFOLIO MANAGEMENT LLC 5.1% 789,421 0% 0.01% $126,070,534
VANGUARD CAPITAL MANAGEMENT LLC 3.5% 549,548 0% 0% $87,762,816
FIRST TRUST ADVISORS LP 3.4% 530,302 +45% 0.06% $84,689,229
STATE STREET CORP 3.2% 491,575 +1.3% 0% $78,822,296
M Holdings Securities, Inc. 3% 462,411 -0.17% 5.1% $73,847,000
RENAISSANCE TECHNOLOGIES LLC 2.2% 335,517 -4.2% 0.08% $53,582,065
GEODE CAPITAL MANAGEMENT, LLC 2.1% 323,267 +1.5% 0% $51,635,373
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.1% 178,598 -4% 0% $28,522,101
ALPS ADVISORS INC 1% 157,840 -4.6% 0.12% $25,207,048
Invesco Ltd. 0.97% 150,196 +135% 0% $23,986,301
NORTHERN TRUST CORP 0.88% 136,711 +3.1% 0% $21,832,745
Bank of New York Mellon Corp 0.77% 119,953 -1% 0% $19,156,454
SYSTEMATIC FINANCIAL MANAGEMENT LP 0.75% 116,248 -2.1% 0.43% $18,565,044
MORGAN STANLEY 0.69% 107,812 -2.8% 0% $17,217,759
GOLDMAN SACHS GROUP INC 0.63% 98,348 +15% 0% $15,706,192
AMERICAN CENTURY COMPANIES INC 0.58% 89,616 +52% 0.01% $14,311,675
TWO SIGMA INVESTMENTS, LP 0.53% 82,797 +329% 0.01% $13,222,681
VANGUARD FIDUCIARY TRUST CO 0.52% 80,169 0% 0% $12,802,989
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 0.48% 75,257 +407% 0.01% $12,018,543
JPMORGAN CHASE & CO 0.46% 70,874 +127% 0% $11,509,228
PRINCIPAL FINANCIAL GROUP INC 0.43% 67,089 +0.16% 0.01% $10,714,113
Manatuck Hill Partners, LLC 0.39% 60,400 0% 3.2% $9,645,880

Institutional Holders of NATIONAL HEALTHCARE CORP - Common Stock (NHC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 10,237,611 $1,635,148,783 +$51,064,373 $159.70 233
2025 Q4 9,956,399 $1,364,489,531 +$63,375,981 $137.09 222
2025 Q3 9,505,211 $1,155,414,745 +$60,724,234 $121.51 204
2025 Q2 9,014,817 $965,006,048 -$2,384,981 $107.01 191
2025 Q1 9,066,636 $841,710,280 -$11,771,082 $92.80 180
2024 Q4 9,179,966 $987,653,080 -$13,768,866 $107.56 184
2024 Q3 9,256,378 $1,164,189,694 +$109,716,288 $125.77 193
2024 Q2 8,465,537 $917,958,537 +$14,615,318 $108.40 175
2024 Q1 8,325,880 $787,159,894 -$27,474,316 $94.51 167
2023 Q4 8,656,920 $800,627,913 +$121,941,956 $92.42 158
2023 Q3 7,360,641 $471,147,949 -$1,313,167 $63.98 130
2023 Q2 7,373,271 $455,943,050 +$11,808,909 $61.82 132
2023 Q1 7,192,355 $417,859,455 +$1,367,697 $58.07 136
2022 Q4 7,170,483 $426,855,165 +$12,334,348 $59.50 119
2022 Q3 6,947,847 $440,296,885 -$9,500,426 $63.34 123
2022 Q2 7,086,089 $495,501,425 +$5,722,290 $69.90 120
2022 Q1 7,057,480 $495,434,845 +$11,068,802 $70.23 120
2021 Q4 6,901,119 $468,895,833 -$7,169,944 $67.94 124
2021 Q3 6,943,485 $485,887,534 -$373,619 $69.98 121
2021 Q2 6,995,038 $488,967,423 -$6,922,679 $69.90 132
2021 Q1 7,059,632 $549,762,154 -$4,802,078 $77.91 127
2020 Q4 7,142,513 $474,488,942 +$5,766,717 $66.41 125
2020 Q3 7,061,440 $439,915,717 -$8,818,406 $62.31 123
2020 Q2 7,195,815 $456,539,095 -$20,860,051 $63.44 133
2020 Q1 7,484,832 $537,131,997 +$36,706,014 $71.73 143
2019 Q4 6,937,225 $598,914,370 +$24,418,953 $86.43 145
2019 Q3 6,716,247 $549,346,214 +$39,171,890 $81.85 134
2019 Q2 6,238,231 $505,759,106 -$6,636,274 $81.15 129
2019 Q1 6,394,014 $485,096,333 +$13,974,813 $75.88 124
2018 Q4 6,178,872 $484,824,336 +$13,261,063 $78.45 125
2018 Q3 6,002,267 $452,346,245 +$13,822,945 $75.37 118
2018 Q2 5,821,653 $409,772,460 +$6,812,041 $70.38 114
2018 Q1 5,738,431 $342,173,756 +$926,994 $59.63 115
2017 Q4 5,722,036 $348,879,261 -$468,221 $60.94 115
2017 Q3 5,663,493 $354,386,234 -$1,462,381 $62.57 109
2017 Q2 5,675,211 $398,054,344 +$8,329,361 $70.14 109
2017 Q1 5,562,786 $396,615,431 +$51,205,944 $71.30 103
2016 Q4 5,569,946 $422,182,620 +$24,273,567 $75.79 102
2016 Q3 5,252,888 $346,476,609 +$3,480,240 $65.99 107
2016 Q2 5,271,622 $341,293,570 +$5,389,348 $64.74 107
2016 Q1 5,140,223 $320,216,000 -$3,506,074 $62.30 106
2015 Q4 5,193,507 $320,464,453 +$7,115,320 $61.70 94
2015 Q3 5,069,211 $307,713,658 -$6,181,790 $60.89 90
2015 Q2 5,148,063 $334,560,423 +$10,481,070 $64.99 90
2015 Q1 4,987,337 $317,736,450 -$1,999,749 $63.71 88
2014 Q4 5,019,455 $315,443,140 -$1,231,095 $62.84 79
2014 Q3 5,042,597 $279,911,289 +$6,394,239 $55.51 86
2014 Q2 4,927,009 $277,319,595 +$1,593,769 $56.29 88
2014 Q1 4,897,476 $273,098,781 +$1,688,542 $55.77 80
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .